This page may be out of date.
Save your draft
before refreshing this page.
Submit any pending changes before refreshing this page.
Hide this message
Discussion about all business, legal & regulatory topics in the generic pharmaceutical industry.
Also feel free to post documents or presentation...
This is the hot topic in pharma.. new growth opportunities in emerging (emerged!) markets; taking advantage of the lack of substitution and charging a premium for 'quality' brands.
Sustainable? If so, where? If not, why not?
Written Nov 13, 2012